Through the chimeric DEREG/Ldlr–/– mouse model experiment, the authors confirmed that Foxp3+ Tregs have a substantial protective effect on AS, and the metabolism of plasma lipoprotein is partially regulated by immune regulation and showed that chronic inflammation could promote cardiovascular diseases (CVDs) by causing metabolic disorder. Here, FOXP3 is linked to Other metabolic disease.